Nucleic acid detection of novel coronavirus of Qingdao Jianma Gene Technology Co., Ltd. is certified by CE.
On March 13th, the COVID nucleic acid test kit (Rapid PCR fluorescence method) of Qingdao Jianma Gene Technology Co., Ltd., a wholly owned subsidiary of the Qingdao based German biotechnology company, was certified by the European Union, indicating that the product conforms to the conformity requirements of the European Union Medical Device Directive and has the access conditions of the European market. It is the only one of the few domestic nucleic acid testing products to enter the European market. One of the products.
JanMa gene has been focusing on the field of rapid nucleic acid detection. It has cooperated with Qingdao University and Qingdao University of science and technology to tackle key problems. It has independently mastered the core technology of rapid PCR. In the past two years, it has launched rapid nucleic acid detection kits such as colorimetry, fluorescence method and other supporting instruments. It has achieved a series of technological breakthroughs, such as one-step detection, nucleic acid free extraction, rapid amplification of nucleic acid, multi-mode result interpretation, pre mixed solid-state reagent, etc., which brings the latest rapid detection product experience and is in the forefront of molecular diagnosis POCT industry.
Certified product information
01 Product Name: sars-cov-2 nuclear acid detection kit (rapid PCR fluorescence method)
Product No.: jm001
Detection: within 30 minutes
Supporting instrument: nd360 rapid PCR instrument / other PCR instruments
Product form: solid reagent, easy to transport and store at room temperature
Product introduction
Order Tel.: + 86-532-8833080515610060982 (manager Yin)
Email: navid@naidesw.com
Post time: Nov-11-2020
